Viewing Study NCT06176261


Ignite Creation Date: 2025-12-24 @ 12:05 PM
Ignite Modification Date: 2025-12-25 @ 8:08 PM
Study NCT ID: NCT06176261
Status: RECRUITING
Last Update Posted: 2025-07-30
First Post: 2023-12-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Sponsor: Sarah Sammons, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module